• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » February 2003 – The CenterWatch Monthly : PDF
February 2003 – The CenterWatch Monthly : PDF

February 2003 – The CenterWatch Monthly : PDF

$79.00

Product Details

Conspiring Forces Behind EDC Adoption

Sponsors and CROs report that electronic data capture (EDC) was used on one-out-of-four clinical studies in 2002, up from only 12% of clinical trials in 2000. But regulatory concerns, lack of a clear market leader, absence of data standards, perceived cost, and difficulties in changing long-established development processes are to blame for slower than anticipated EDC adoption rates. The market is now undergoing structural change. Over the short-term, consolidation is expected to weed out poorer-performing players. Several sponsors also report bringing their EDC initiatives in-house.

Jumping on the Clinical Trial Lab Services Bandwagon

An estimated $1.2 billion will be spent on contract central laboratory services to support clinical trials in 2003. Increases in phase IV research programs, gene-based testing and the use of diagnostics are expected to drive more rapid market growth to 13%–15% annually. Covance, long the market leader in providing contract laboratory services for clinical trials, faces intensifying competition from large central laboratory services and from other CROs seeking a differentiated, higher margin business now ripe for consolidation and globalization.

Also in this issue:

  • CentreStage Europe: Phase IV a Rising Priority
  • Eye On: Depression
  •  

  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing